Delivery Order SPE2DB20D7061-SPE2DB24FSPM6

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,532.79 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,150,864 units of the prescription medication Entecavir 0.5 mg tablets. This delivery order is a part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $3,067.66 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Entecavir 0.5 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a $1,743.42 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4,565,827,750 units of the prescription drug Entecavir 0.5 mg tablets. This contract has an ultimate completion date of September 17, 2024 and was awarded on September 16, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several large Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company. The $12,994.06 order is for the supply of Entecavir 0.5 mg tablets to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $7,259.18, is for the delivery of the pharmaceutical product Entecavir 0.5 mg Tablets. The ultimate completion date for this delivery order is April 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has also been...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,630.72 firm-fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets. The contract has an ultimate completion date of June 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Entecavir 0.5 mg tablets. The contract has a potential value of $5,038.26 and a completion date of January 5, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at four thousand eight hundred ninety-three dollars and seventy-two cents ($4,893.72) to Amerisourcebergen Drug Corporation for the supply of entecavir 0.5 mg tablets. Under this order, Amerisourcebergen will deliver thirty (30) tablets to a facility in Conshohocken, Pennsylvania by September 19, 2023 in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,758.86 Firm Fixed Price Delivery Order is for the supply of 4564950562 - Entecavir 0.5 mg Tablet 30s, with a period of performance through June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the...
This is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,309.60 firm fixed-price contract is for the delivery of 4559908027 Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has an ultimate completion date of February 13, 2023. AmerisourceBergen is a for-profit organization...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB24FSPM6
    Delivery Order

This is a $8,263.76 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,525 units of the pharmaceutical product Entecavir 0.5 mg tablets. The order has an ultimate completion date of August 22, 2024 and is not set-aside for any special designation. AmerisourceBergen, as a major pharmaceutical distributor, holds multiple indefinite delivery contracts with federal agencies such as the DLA and Department of Justice to provide a wide range of essential medical commodities, including specialty medications, drugs, and medical supplies, in support of military treatment facilities, veterans' healthcare, and other government healthcare programs.

Generated 11/20/24, 9:19 AM